Sight Sciences, Inc. (SGHT)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Paul Badawi | Co-Founder, President, CEO & Director | 871.59k | -- | 1975 |
| Dr. David Badawi M.D. | Founder, CTO & Director | -- | -- | 1970 |
| Ms. Alison Perry Bauerlein | CFO & Treasurer | 378.6k | -- | 1981 |
| Mr. Matthew W. Link | Chief Commercial Officer | 157.61k | -- | 1975 |
| Mr. Sam Boong Park | Chief Operating Officer | 531.78k | -- | 1961 |
| Mr. Jeremy B. Hayden | Chief Legal Officer | -- | -- | 1970 |
| Mr. Steve R. Tamayo Jr. | VP and Chief Ethics & Compliance Officer | -- | -- | -- |
| Dr. Reay H. Brown M.D. | Chief Medical Officer | -- | -- | -- |
| Mr. Stephen B. Thau J.D. | Secretary | -- | -- | -- |
| Mr. Jim Rodberg | VP of Finance & Corporate Controller | -- | -- | -- |
Sight Sciences, Inc.
- Sector:?
- Healthcare
- Industry:? Medical Devices
- Full Time Employees:?
- 214
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.
Corporate Governance
Upcoming Events
November 8, 2024 at 12:00 AM UTC
Sight Sciences, Inc. Earnings Date
Recent Events
June 3, 2024 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)